Universal Health Services has promised to pay $122 million to end 19 suits under the False Claims Act that had accused the behavioral health hospital company of cheating federal health care subsidy programs and putting profit over patient care, the U.S. Department of Justice announced Friday…
Read this piece in its entirety at Law360.
GlaxoSmithKline is asking the U.S. Supreme Court to upend a Third Circuit ruling in a case over the marketing of the diabetes medication Avandia, saying the appeals court had taken an “impossibly capricious view” of the drug company’s duty to provide information to regulators…
Read this piece in its entirety at Law360.
The First Circuit said Wednesday that Insys Therapeutics Inc. founder John Kapoor and other former executives can’t dodge prison while they appeal convictions on charges of scheming to bribe doctors to prescribe the company’s fentanyl spray, but they’re asking the trial court to put off their prison surrender date…
Read this piece in its entirety at Law360.
Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins in cases related to the same product…
Read this piece in its entirety at Law360.
President Donald Trump announced Monday the end of a “saga” involving his administration and 3M Co., which had pushed back against White House requests to stop exporting medical grade masks amid the coronavirus pandemic…
Read this piece in its entirety at Law360.
Mike LaSusa 